Respiratory syncytial virus immune globulin (RSV IG) Side Effects
Please note - some side effects for Respiratory syncytial virus immune globulin (RSV IG) may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
Side Effects by Body System - for Healthcare Professionals
Applies to: intravenous solution
Renal side effects associated with sucrose-containing IGIV infusion have included increased serum creatinine, increased BUN level, oliguria, anuria, acute renal failure, acute tubular necrosis, proximal tubular nephropathy, and osmotic nephrosis.
Other side effects has included fever/pyrexia (6%) and overdose effect (1%). Pallor, cold/clammy skin, gagging, and fluid overload have been reported rarely.
Other side effects associated with other IGIV derivatives have included flushing. This effect is often related to the rate of infusion.
Respiratory side effects have included respiratory distress (2%), wheezing (2%), rales (1%), tachypnea (1%), and hypoxia/hypoxemia (1%). Cyanosis, cough, and rhinorrhea have been reported rarely.
Respiratory side effects associated with other IGIV derivatives have included dyspnea. This effect is often related to the rate of infusion.
Gastrointestinal side effects have included vomiting (2%), diarrhea (1%), and gastroenteritis (1%).
Gastrointestinal side effects associated with other IGIV derivatives have included abdominal cramps. This effect is often related to the rate of infusion.
Cardiovascular side effects reported in 1% of patients have included fluid overload, tachycardia, increased pulse rate, and hypertension. Edema, hypotension, and heart murmur have been reported rarely.
Cardiovascular side effects associated with other IGIV derivatives have included blood pressure changes, palpitations, and chest tightness. These effects are usually related to the rate of infusion.
The CARDIAC study reported an increase in frequency of cardiac surgery in children with left and right shunts. All enrollees (n=429) had preexisting congenital heart disease of less than 48 months duration at time of enrollment. The study also reported a greater frequency of severe and life-threatening side effects associated with the cardiac surgery.
Dermatologic side effects have included rash (1%). Eczema has been reported rarely.
Dermatologic side effects associated with other IGIV derivatives have included pruritus. This effect is usually related to the rate of infusion.
Local side effects have included inflammation at injection site.
Nervous system side effects have rarely included sleepiness.
Nervous system side effects associated with other IGIV derivatives have included dizziness and anxiety. These effects are often related to the rate of infusion.
Ocular side effects have rarely included conjunctival hemorrhage.
Musculoskeletal side effects associated with other IGIV derivatives have included myalgia and arthralgia. These effects are often related to the rate of infusion.
Hypersensitivity side effects, including anaphylactic reactions, have been associated with other IGIV derivatives.
Aseptic meningitis syndrome has been associated with high doses (2 g/kg) of IGIV.
Aseptic meningitis of unknown etiology has been reported in three pediatric patients during RSV-IGIV therapy in the PREVENT trial. Subsequent findings reported one child to have a presumptive diagnosis of enteroviral infection, and another child to have an unconfirmed diagnosis of Herpes simplex meningitis related to treatment with acyclovir. The third child developed fever, vomiting, and malaise associated with 21 cells per mm3 in the cerebrospinal fluid.
Immunologic side effects associated with other IGIV derivatives have rarely included aseptic meningitis syndrome.Top
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.